Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
Clinical Trial
SIMCERE PHARMA (02096.HK): SIM0712 Cleared for Atopic Dermatitis Trial
Tags:
SIMCERE PHARMA
02096.HK
Clinical Trial
2026-11-16
CANSINOBIO (06185.HK): Td5cp Cleared for Trial in Children Aged 4-5
Tags:
CANSINOBIO
06185.HK
Clinical Trial
2026-11-16
RIBOLIFE (06938.HK): EU filing for Phase I trial of SR122
Tags:
RIBOLIFE
06938.HK
Clinical Trial
2026-11-10
SIMCERE PHARMA (02096.HK): SIM0709 trial cleared in Germany
Tags:
SIMCERE PHARMA
02096.HK
Clinical Trial
2026-11-09
CSPC PHARMA (01093.HK): SYS6055 In Vivo CAR-T Trial Starts
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-11-06
CSPC PHARMA (01093.HK): SYH9061 IPF Phase II Trial Starts
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-11-06
JIUYUAN GENE (02566.HK): JY54-2 IND Accepted for Diabetes, Weight
Tags:
JIUYUAN GENE
02566.HK
Clinical Trial
2026-11-06
BOAN BIOTECH (06955.HK): BA2201 cleared to enter IBD clinical trial
Tags:
BOAN BIOTECH
06955.HK
Clinical Trial
2026-11-06
BRII-B (02137.HK): presents ENRICH and ENHANCE Phase II data at AASLD, combo achieving up to 41.9% HBsAg clearance
Tags:
BRII-B
02137.HK
Clinical Trial
2026-11-06
CSPC PHARMA (01093.HK): SYS6062 Phase I/II trial starts in China
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-11-05
CLOUDBREAK-B (02592.HK): CBT-001 Meets Phase III Endpoints in Pterygium
Tags:
CLOUDBREAK-B
02592.HK
Clinical Trial
2026-11-05
FOSUN PHARMA (02196.HK): HLX109 cleared for Phase I trial in Australia
Tags:
FOSUN PHARMA
02196.HK
Clinical Trial
2026-11-04
FOSUN PHARMA (02196.HK): FXS6837 starts Phase III trial in China
Tags:
FOSUN PHARMA
02196.HK
Clinical Trial
2026-11-04
KINTOR PHARMA-B (09939.HK): long-term safety trial of KX-826 tincture 1.0% for AGA completed
Tags:
KINTOR PHARMA-B
09939.HK
Clinical Trial
2026-11-03
JENSCARE-B (09877.HK) : presents LuX-Valve Plus trial results at TCT 2026
Tags:
JENSCARE-B
09877.HK
Clinical Trial
2026-11-02
CSPC PHARMA (01093.HK): Starts Phase I/II Trial of SYS6043 in China
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-10-30
ALPHAMAB-B (09966.HK) JSKN033 doses first patient in Phase III cervical cancer study
Tags:
ALPHAMAB-B
09966.HK
Clinical Trial
2026-10-28
CSPC PHARMA (01093.HK) starts Phase I trial of SYS6077 injection, an off-the-shelf mRNA cancer vaccine
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-10-28
DUALITYBIO-B (09606.HK): DYNASTY-Breast02 meets primary endpoint, PFS gain modest, clinical benefit may be limited
Tags:
DUALITYBIO-B
09606.HK
Clinical Trial
2026-10-26
LEADS BIOLABS-B (09887.HK): First Patient Enrolled in Phase Ib/II Study of Vescuterlimab in mCRC
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Trial
2026-10-16
1
2
3
4
5
Next
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App